Rare diseases
Investigational molecules
Locations
Back to the Netherlands23 clinical trials in Dirksland, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of ISIS 678354 for Patients with Severe High Triglycerides
The NetherlandsStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
The NetherlandsStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
The NetherlandsStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
The NetherlandsStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
The NetherlandsStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
The NetherlandsStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
The NetherlandsEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
The NetherlandsStudy Comparing Two Treatment Sequences of CDK4/6 Inhibitors (Abemaciclib, Palbociclib, or Ribociclib) in Hormone Receptor Positive Advanced Breast Cancer
The NetherlandsStudy of Trastuzumab, Pertuzumab, and Chemotherapy Combination with Response-Guided Treatment for Patients with HER2-Positive Breast Cancer
The NetherlandsStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions. Studies evaluate new medications for stroke prevention in patients with atrial fibrillation.
Multiple trials targeting improved outcomes in heart disease and stroke prevention through innovative therapeutic approaches.
Comprehensive research examining treatments for HER2-positive and hormone receptor-positive breast cancer, including innovative approaches to chemotherapy and hormone therapy.
Advanced clinical trials exploring personalized treatment strategies and quality of life improvements for breast cancer patients.
Studies addressing Type 2 Diabetes and various metabolic conditions, including research on thyroid disorders and lipid abnormalities.
Innovative therapeutic approaches targeting improved patient outcomes in metabolic disorders through targeted interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
